Please login to the form below

Not currently logged in
Email:
Password:

Clovis

This page shows the latest Clovis news and features for those working in and with pharma, biotech and healthcare.

AZ/Merck's Lynparza improves survival in certain prostate cancers

AZ/Merck's Lynparza improves survival in certain prostate cancers

The new data could help Lynparza to gain an advantage over its main rival in mCRPC – Clovis’ Rubraca (rucaparib). ... Clovis’ PARP inhibitor was approved by the FDA a few days before Lynparza for the treatment of BRCA-mutated metastatic mCRPC.

Latest news

More from news
Approximately 8 fully matching, plus 38 partially matching documents found.

Latest Intelligence

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    Jacob Plieth at Vantage recently highlighted this trend, with companies like Tesaro, Clovis Oncology and Acadia failing to meet revenue expectations for their new launches.

  • Deal Watch table for November 2013 Deal Watch table for November 2013

    500. Clovis / Servier. Licence. Servier licenses lucitanib excluding China, Japan and the US. ... 425. EOS /Clovis. Acquisition. Lucitanib for FGF aberrant breast cancer. 420.

  • Pharma deals during November 2013 Pharma deals during November 2013

    It was clearly busy times at Clovis this month with two major announcements, firstly the acquisition of the privately owned Italian company, Ethical Oncology Science (EOS) for an upfront payment of ... In addition, Clovis is to pay $65m on the FDA

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Roche's Julie Warner joins Boyds Roche's Julie Warner joins Boyds

    She has previously held positions at Clovis Oncology UK, Genzyme and Gregory Fryer Associate, and was most recently senior regulatory programme manager at Roche.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Infographics